Skip to main content
Clinical Trials/CTRI/2025/03/081557
CTRI/2025/03/081557
Not yet recruiting
Phase 2

Singla Arm Clinical Study To Assess The Efficacy Of Trikantakadya Ghrita IN Mutrakrucchra With Special Reference To Urine Routine And Microscopic Examination

Dr Dadasaheb Namdev Raut1 site in 1 country70 target enrollmentStarted: March 12, 2025Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Dr Dadasaheb Namdev Raut
Enrollment
70
Locations
1
Primary Endpoint
To study the effect of Trikantakadya Ghrita in Mutrakrucchra with special reference to urine routine and microscopic examination

Overview

Brief Summary

Urinary tract infection (UTI) is the most common infection worldwide.

In the developing countries, incidence and prevalence of UTI would be similar owing to the relatively short duration of illness experienced with ready access to healthcare services.

In recent years Ayurvedic drugs are creating interest in the people by clinically proven effects. Considering this the drug “Trikantakadya ghrita” have been taken in management of Mutrakrucchra which is described by Yogaratnakar in Mutrakrucchra adhyay.

Trikantakadya ghrita contains Dravyas like Gokshur, Eranda, Mula, Shatavari, Kusha, Kasha, Shara, Ikshu, Nala, Ervaru. All of those drugs have snigdha guna in common as well as vata pittahara properties.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1 Age between 20yrs – 60 years.
  • 2 Patients of both gender.
  • 3 All patients with symptoms of- Mutrakrucchrata (dysuria) Tvarata (Urgency) Dourgandhya(foul smelling) Sheetapurvak jwara (fever with Chills) Bastishool(pain over suprapubic area) Muhur mutrata (Frequency of micturition).

Exclusion Criteria

  • 1 Age group below 20 years and above 60 years.
  • 2 K/C/O Diabetes mellitus.
  • 3 Renal Failure.
  • 4 Immune compromised Patients.
  • 5 Urinary Tract Malignancy.
  • 6 UTI due to any cause of bladder out-flow obstruction.
  • 7 Pregnancy.
  • 8 Any surgical intervention which leads to acute symptoms of UTI.
  • 9 Not willing to give consent.
  • 10 K/C/O- Acute Glomerulonephritis 11 K/C/O- Nephrotis Syndrome.

Outcomes

Primary Outcomes

To study the effect of Trikantakadya Ghrita in Mutrakrucchra with special reference to urine routine and microscopic examination

Time Frame: 7 Days

Secondary Outcomes

  • 1 To study the mutrakrucchra according to Ayurveda.(2 To study the urinary tract infection.)

Investigators

Sponsor
Dr Dadasaheb Namdev Raut
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Dadasaheb Namdev Raut

LRP Ayurvedic Medical College and Hospital

Study Sites (1)

Loading locations...

Similar Trials